Search Results

As Chief Matchmaker, I recently had the pleasure of speaking with Beth Fleck, Director of In Vitro Pharmacology Mark:  “Beth, why did you decide to join Crinetics?” Beth:  “Yes.  There are a lot of learning opportunities at Crinetics.  Mark:  “Beth, why would someone want you as their boss?” Beth:  “Well, I enjoy training and mentoring team members. 

Mark recently discussed this exciting opportunity with Beth Fleck, Director of In Vitro Pharmacology

Our Chief Matchmaker, Mark Schmeizl, had a great conversation about this position with Beth Fleck, Director

Marshall About this episode Fiona Marshall got fascinated with GPCRs after attending a lecture on how the beta-adrenergic receptor in the heart is activated by adrenaline, during her undergraduate studies at Bath University

development of approaches to quantify ligand bias and the identification of ACKR3 as an endogenously beta-arrestin-biased signal transduction mechanisms of GPCRs, such as the formation of complexes between G proteins and beta-arrestins

biased agonism, with the development of approaches to quantify ligand bias and the identification of beta-arrestin-biased signal transduction mechanisms of GPCRs, such as the formation of complexes between G proteins and beta-arrestins